Thu.Jun 19, 2025

article thumbnail

No, DTC Pharma Ads Won’t Disappear Anytime Soon

World of DTC Marketing

Critics of direct-to-consumer (DTC) pharma advertising have called for a ban. They argue it misleads patients, drives up drug costs, and pushes people to pressure doctors for drugs they may not need. They’re not wrong about the consequences, but they’re also ignoring a core reality: DTC marketing isn’t going anywhere in the U.S. anytime soon. Why? Because too many influential players benefit from the status quo. 1.

Pharma 253
article thumbnail

The Benefits of Establishing a Data-driven Culture in Healthcare

MedCity News

Ultimately, the benefits of establishing a data-driven culture reach far beyond improved analytics. It enables a smarter, faster, and more inclusive decision-making process that leads to better care for patients, reduced provider burnout, and stronger financial resilience The post The Benefits of Establishing a Data-driven Culture in Healthcare appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New biosimilar pathways – key takeaways from the EMA’s draft reflection paper

European Pharmaceutical Review

The European Medicines Agency (EMA) has published a draft reflection paper that signals a potential evolution in the regulatory landscape for biosimilar development within the EU. 1 Rather than representing a radical break from established practice, the document builds on decades of scientific and regulatory experience, proposing that – under certain well-defined conditions – the demonstration of bio-similarity might rely more heavily on advanced analytical characterisation and pharmacokinetic (

article thumbnail

Taking The Wheel: A Proactive Approach to Improving Longevity

MedCity News

When you equip patients with a deeper understanding of their bodies, they are better prepared to act on medical advice. The post Taking The Wheel: A Proactive Approach to Improving Longevity appeared first on MedCity News.

Medical 243
article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

eXmoor and Signadori Bio enter cell therapy partnership

PharmaTimes

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs eXmoor and Signadori Bio enter cell therapy partnership by Emily Kimber | 19th Jun 2025 | News Signadori is advancing a platform designed to overcome the challenges of treating solid cancers eXmoor Pharma and Signadori Bio have entered into a partnership aimed at advancing a gene-modified monocyte-derive

article thumbnail

Discover the Hidden Costs of Siloed Systems

MedCity News

Twitter Facebook LinkedIn RSS Subscribe via email Newsletter Signup Send Tips Webinars eBooks Open navigation MedCity News Toggle Search News Health Tech BioPharma Devices & Diagnostics Consumer / Employer Contributors MedCity Influencers Events INVEST INVEST Digital Health Podcasts Research Newsletters Newsletter Signup Send Tips Webinars eBooks Twitter Facebook LinkedIn RSS Subscribe via email Search for: Search Sponsored Post Discover the Hidden Costs of Siloed Systems Is your provider d

More Trending

article thumbnail

Dismay but little surprise as NICE rejects Alzheimer's drugs

pharmaphorum

Eli Lilly and Eisai's hopes of making their Alzheimer's disease therapies available to NHS patients in England have been knocked back once again

article thumbnail

BASF Opens GMP Manufacturing Facility in Michigan

PharmaTech

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer

article thumbnail

Gilead Sciences’ Yeztugo receives approval from US FDA for HIV

Pharmaceutical Technology

The FDA has approved Gilead Sciences' injectable product, Yeztugo (lenacapavir), as a pre-exposure prophylaxis (PrEP) against HIV.

FDA 66
article thumbnail

Precision, speed, impact: Evolving mass spectrometry for medical science

pharmaphorum

Join us for an insightful conversation with Melissa Sherman from MOBILion as we discuss the future of molecular science and the impact of mass spectrometry. Tune in to this podcast interview for an in-depth look at the latest innovations in the field.

article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Pharma 52
article thumbnail

What is a Pharma Ad Exchange?

Pharma Marketing Network

Imagine a high-speed auction house that matches digital ad space with targeted pharmaceutical ads in milliseconds. That’s essentially what an Ad Exchange is—and for pharma marketers, it’s reshaping the way campaigns reach healthcare professionals (HCPs) and patients. In a world where precision and privacy matter more than ever, pharma ad exchanges offer a streamlined, scalable, and data-driven way to deliver the right message to the right audience.

Pharma 52
article thumbnail

Draig secures $140m for neuropsychiatric disorder therapies

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Media 52
article thumbnail

NICE concludes decision for two Alzheimer’s treatments

European Pharmaceutical Review

The National Institute for Health and Care Excellence (NICE) has recommended against approving Leqembi (lecanemab) and Kisunla (donanemab) to treat mild cognitive impairment or mild dementia caused by Alzheimer’s, in its final draft guidance. “We have done everything we possibly can to try and achieve a positive outcome in our assessments of these treatments, including providing an additional opportunity for new evidence to be submitted,” stated Helen Knight, Director of medicines evaluation at

article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

article thumbnail

Eli Lilly and Eisai’s Alzheimer’s drugs denied NHS use due to high costs

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Media 59
article thumbnail

EIT Health Ireland–UK Expands European Network with Three New Members

PharmaTech

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer

article thumbnail

Actio gains $66m to advance small molecule therapeutics pipeline

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Google Just Broke the SEO Playbook. Now What?

Healthcare Success

Find Out How Google’s AI-Powered Search Is Rewriting Healthcare Marketing For healthcare marketers, this isn’t just a minor update. It’s a fundamental shift in how patients search for care and how your brand shows up (or doesn’t). What’s Driving the Shift? Three important things: AI Mode A new way to search in Google. Find it as a tab or button within the Google search interface next to Regular Search Results.

article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

BioOrbit eyes 2026 for pre-clinical trials of space manufactured protein crystals

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Pharma Pulse 6/19/25: Strategic Planning in the Rebate Economy; The Truth About AI Adoption Speed in Clinical Research

Pharmaceutical Commerce

Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.

article thumbnail

Why hospitals need episode-based intelligence to prepare for CMS’s TEAM Model

Clarify Health

Foreword by Clarify President & Founder, Todd Gottula The new CMS TEAM model marks a pivotal moment for hospitals: mandatory participation, financial accountability, and heightened expectations around surgical episodes that have historically driven massive spend variability. At Clarify, we view this as more than a regulatory shift — it’s a defining opportunity for hospitals to build lasting competitive advantage through smarter, data-driven value-based care.

Safety 52
article thumbnail

Establishing Additional Transparency

Pharmaceutical Commerce

In the third part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, explains how a flat admin fee model can potentially create more value for both payers and patients.

Pharma 52
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Why hospitals need episode-based intelligence to prepare for CMS’s TEAM Program

Clarify Health

Foreword by Clarify President & Founder, Todd Gottula CMS’s new TEAM model marks a pivotal moment for hospitals: mandatory participation, financial accountability, and heightened expectations around surgical episodes that have historically driven massive spend variability. At Clarify, we view this as more than a regulatory shift — it’s a defining opportunity for hospitals to build lasting competitive advantage through smarter, data-driven care.

article thumbnail

ASCO 2025: Real-World Outcomes of Frontline ICI Therapy in BRAF-Mutated Melanoma in the Community Setting

Pharmacy Times

Janet Espirito, PharmD, discusses real-world outcomes from a large community oncology study showing that patients with BRAF-mutated melanoma—including those with brain metastases—experienced similar benefit from frontline immune checkpoint inhibitor (ICI) therapy.

article thumbnail

How Medicare Eligibility Affects Healthcare Use in Adults with Psychological Distress

Pharmaceutical Commerce

A cross-sectional study investigates whether becoming eligible for Medicare at age 65 is linked to changes in healthcare use among individuals experiencing mental health challenges.

article thumbnail

Tafasitamab-Cxix With Rituximab, Lenalidomide Approved by FDA for Relapsed/Refractory Follicular Lymphoma

Pharmacy Times

Following robust progression-free survival indications in the phase 3 inMIND trial, the FDA granted approval to tafasitamab-cxix in combination with standard-of-care lenalidomide and rituximab for patients with relapsed or refractory follicular lymphoma.

FDA 29
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Behind the Headlines, Episode 19: CGT Cost Pressures, BioNTech’s CureVac Move, and Spain’s CAR-T Model

PharmaTech

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer

article thumbnail

OPC 2025: Early and Metastatic GI Cancers See Practice Changing Trial Results

Pharmacy Times

At the 2025 Oncology Pharmacists Connect (OPC) meeting, Courtney Cavalieri, PharmD, BCOP, presented clinical trial findings in gastrointestinal (GI) cancers—including colon, gastric, pancreatic, and metastatic colorectal cancer—that highlight the expanding role of immunotherapy and targeted treatments.

22
article thumbnail

UK and US governments pursue contrasting vaccine strategies

Pharmaceutical Technology

While the outlook for vaccines in the US looks bleak under Trump's administration, the UK is pressing ahead with securing its vaccine future.

article thumbnail

OPC 2025: Advancing Precision Oncology Through Pharmacy-Led Innovation

Pharmacy Times

At the 2025 Oncology Pharmacists Connect (OPC) meeting, Mya Tran, PharmD, BCOP, highlights the clinical promise, operational challenges, and evolving role of pharmacists in implementing precision medicine and genomics-driven cancer care.

article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.